SkinHealth Systems Inc. SKIN
Set alert
10.06 USD -0.32 -3.08%
As of Nov 3, 11:18 AM ET
10.00 Day range 10.41
9.68 52-week range 34.80
- YTD
- +623.74%
- 1 year
- +634.31%
- Open
- 10.25
- Prev close
- 10.38
- Mkt cap
- 65.54M
- Vol
- 19.01K
- Avg vol
- 26.71K
- EPS
- -4.60
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.00
- High
- 10.41
- Forward P/E
- -9.00
- Beta
- 0.91
- Short ratio
- 8.46
- Inst. own
- 87.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.58
- 200-d avg
- 2.17
- 1y target
- 1.72
2Y chart
Events in this range
- Nov 12, 2024Earnings: -0.15; estimate -0.12; surprise -25%
- Nov 13, 2024Rating: Canaccord Genuity · Hold → Hold
- Oct 14, 2026Split: 1 for 20
Signals (88)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 26, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 8, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| RSI: Overbought | Jul 7, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 10, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 4, 2026 | 5 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| MACD: Sell Signal | May 8, 2026 | 5 months ago |
Newest 20 of 88.
Key statistics
- Market cap
- 178.74M
- Enterprise value
- 390.66M
- Trailing P/E
- 0.00
- Forward P/E
- -9.00
- PEG ratio
- 0.00
- Price / sales
- 0.51
- Price / book
- 2.99
- EPS (TTM)
- -0.39
- Beta
- 0.91
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -8.10%
- Revenue (TTM)
- 347.62M
- Revenue growth
- -19.10%
- Free cash flow
- -375.50K
- Total cash
- 358.89M
- Total debt
- 568.33M
- Return on equity
- -37.64%
- Shares outstanding
- 124.12M
- Short % of float
- 16.11%
- 50-day average
- 1.58
- 200-day average
- 2.17
Analyst view
Consensus: hold
Hold
Price target (mean) 1.72 -82.9% downside
Now 10.06
- Target (low)
- 1.00
- Target (mean)
- 1.72
- Target (high)
- 2.00
Ratings (0m) 10 0 buy · 7 hold · 3 sell
- Strong buy0
- Buy0
- Hold7
- Sell0
- Strong sell3
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate -0.09.
Financials — quick view
SKIN Revenue — quarterly 72.11M
SKIN Net income — quarterly -2.67M
SKIN EPS — quarterly -0.40
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | -0.12 | -0.15 | -0.03 | -25.00% |
| Aug 8, 2024 | Jun 1, 2024 | -0.05 | -0.10 | -0.05 | -100.00% |
| Aug 8, 2024 | Jun 1, 2024 | -0.05 | — | — | — |
| May 9, 2024 | Mar 1, 2024 | -0.14 | -0.10 | +0.04 | +28.57% |
| May 9, 2024 | Mar 1, 2024 | -0.14 | — | — | — |
| Mar 12, 2024 | Dec 1, 2023 | -0.11 | -0.07 | +0.04 | +36.36% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | Canaccord Genuity | main | Hold | Hold |
| Aug 12, 2024 | Canaccord Genuity | main | Hold | Hold |
| Aug 9, 2024 | Piper Sandler | reit | Underweight | Underweight |
| Jul 26, 2024 | Stifel | main | Hold | Hold |
| Jul 11, 2024 | Piper Sandler | main | Underweight | Underweight |
| May 13, 2024 | DA Davidson | main | Buy | Buy |
About SkinHealth Systems Inc.
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- United States
- Website
- beautyhealth.com
News
- SkinHealth Systems Inc. (SKIN) Expected to Beat Earnings Estimates: Should You Buy?
- SkinHealth Systems to Report Third Quarter 2026 Financial Results on November 5, 2026
- SkinHealth Systems Inc. (SKIN) Soars 9.0%: Is Further Upside Left in the Stock?
- Full Transcript: Beauty Health Q2 2026 Earnings Call
- Niagen Bioscience (NASDAQ:NAGE) and Beauty Health (NASDAQ:SKIN) Head to Head Review
- SkinHealth Systems Announces Reverse Stock Split
- e.l.f. SKIN's Save Your e.l.f. Hypochlorous Mist Helps Soothe Stress in every e.l.f.ing mist-mergency
- Hydrafacial Introduces HydraClear™ Treatment Booster to Clarify Blemish-Prone Skin
- Contrasting Beauty Health (NASDAQ:SKIN) and Betterware de Mexico SAPI de C (NYSE:BWMX)
- SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe
Your note
Sign in to keep a note on SKIN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BECK MARLA MALCOLM | Chief Executive Officer | Stock Award(Grant) | Apr 8, 2024 | 1,078,210 |
| CAPELLAS MICHAEL D | Director | Stock Award(Grant) | Jul 7, 2024 | 276,146 |
| FEW JULIUS | Director | Stock Award(Grant) | Jul 7, 2024 | 194,341 |
| GRUBER DESIREE | Director | Sale | Nov 19, 2024 | 119,514 |
| KERRICK MICHELLE C. | Director | Stock Award(Grant) | Jul 7, 2024 | 116,762 |
| MILLER BRIAN CHRISTOPHER | Director | Stock Award(Grant) | Jul 7, 2024 | 169,984 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.99% | 18,603,037 | 26.79M | Sep 29, 2024 |
| Janus Henderson Group PLC | 9.03% | 11,209,408 | 16.14M | Sep 29, 2024 |
| Blackrock Inc. | 4.53% | 5,620,752 | 8.09M | Sep 29, 2024 |
| Vanguard Group Inc | 4.46% | 5,536,433 | 7.97M | Sep 29, 2024 |
| Braidwell LP | 3.26% | 4,049,694 | 5.83M | Sep 29, 2024 |
| Jacobs Levy Equity Management, Inc. | 2.01% | 2,499,652 | 3.60M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Janus Henderson Contrarian Fund | 8.96% | 11,117,965 | 16.01M | Sep 29, 2024 |
| Fidelity Growth Company Fund | 3.10% | 3,848,924 | 5.54M | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 2.17% | 2,698,071 | 3.89M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.59% | 1,979,456 | 2.85M | Oct 30, 2024 |
| Fidelity Growth Company K6 Fund | 1.15% | 1,430,456 | 2.06M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.02% | 1,266,061 | 1.82M | Sep 29, 2024 |